O’Connor joins TG Therapeutics as CSO; plus changes at FogPharma, Gemini, Dicerna, Akcea and more
Cancer and autoimmune company TG Therapeutics Inc. (NASDAQ:TGTX) hired Owen O’Connor as CSO. He was director of the Center for Lymphoid Malignancies at Columbia University Medical Center.
RNAi company Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) said retiring CFO Jack Green will be succeeded by Douglas Pagán, effective May 26. Pagán was CFO of KSQ Therapeutics Inc.
FogPharma hired Tony Gibney as CFO and CBO, both newly created positions. He was EVP and CBO of Achillion Pharmaceuticals Inc. The Harvard University spinout is developing cell-penetrating miniproteins to treat cancer...